On Tuesday, Repligen Corp. (NASDAQ: RGEN) was 1.53% up from the session before settling in for the closing price of $144.49. A 52-week range for RGEN has been $110.45 – $211.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 31.42% over the last five years. When this article was written, the company’s average yearly earnings per share was at -17.76%. With a float of $52.07 million, this company’s outstanding shares have now reached $55.77 million.
The firm has a total of 1783 workers. Let’s measure their productivity. In terms of profitability, gross margin is 41.15%, operating margin of 1.56%, and the pretax margin is 1.69%.
Repligen Corp. (RGEN) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Repligen Corp. stocks. The insider ownership of Repligen Corp. is 7.02%, while institutional ownership is 100.81%. The most recent insider transaction that took place on Sep 10 ’24, was worth 3,211,481. Before that another transaction happened on Aug 02 ’24, when Company’s Senior VP, R&D sold 7,148 for $159.35, making the entire transaction worth $1,139,016. This insider now owns 12,288 shares in total.
Repligen Corp. (RGEN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -17.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.71% during the next five years compared to 15.08% growth over the previous five years of trading.
Repligen Corp. (NASDAQ: RGEN) Trading Performance Indicators
You can see what Repligen Corp. (RGEN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.56. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.64. Likewise, its price to free cash flow for the trailing twelve months is 68.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.04, a number that is poised to hit 0.34 in the next quarter and is forecasted to reach 1.91 in one year’s time.
Technical Analysis of Repligen Corp. (RGEN)
Analysing the last 5-days average volume posted by the [Repligen Corp., RGEN], we can find that recorded value of 0.83 million was better than the volume posted last year of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 49.42%. Additionally, its Average True Range was 6.45.
During the past 100 days, Repligen Corp.’s (RGEN) raw stochastic average was set at 52.33%, which indicates a significant increase from 50.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.25% in the past 14 days, which was lower than the 53.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $143.60, while its 200-day Moving Average is $165.40. Now, the first resistance to watch is $148.14. This is followed by the second major resistance level at $149.59. The third major resistance level sits at $152.15. If the price goes on to break the first support level at $144.13, it is likely to go to the next support level at $141.57. Now, if the price goes above the second support level, the third support stands at $140.12.
Repligen Corp. (NASDAQ: RGEN) Key Stats
There are 55,876K outstanding shares of the company, which has a market capitalization of 8.22 billion. As of now, sales total 638,760 K while income totals 41,580 K. Its latest quarter income was 154,070 K while its last quarter net income were 3,320 K.
